Today, if you are unwell, your symptoms are the key driver of your diagnosis and treatment. The practice of medicine will change in the future, and Matt Fox describes a new approach to address the cause of an individual’s underlying disease by utilizing genetic applications. This approach has the potential to become mainstream in the coming years as technologies improve. Matt Fox is driven to find solutions where others see barriers. Matt currently serves as Chief Executive Officer for Pairnomix, a genetic research company focused on rare neurological disease; as a Board Member for Proximagen, a clinical stage biotech company; and as Treasurer of the Edina School Board. His previous experience includes leading corporate strategy on the executive team at Upsher-Smith Laboratories, and a decade as a professional healthcare investor, last working as a Portfolio Manager at Bank am Bellevue in Zurich, Switzerland. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx